文献速递炎症性肠病

儿童期起病炎症性肠病患者的成年身高:全国人群队列研究

Adult height in patients with childhood-onset inflammatory bowel disease: a nationwide population-based cohort study.
PubMed 文献 · Aliment Pharmacol Ther · 2020-03-04

基于瑞典全国登记数据,纳入1990-2014年确诊的4201例儿童期起病IBD患者,分析其成年身高。IBD患者成年身高低于参考个体(校正平均身高差-0.9 cm)及健康同胞(-0.8 cm),克罗恩病比溃疡性结肠炎更矮,青春期前起病及病程较重者身高降低更明显。

要点

  • 儿童期起病IBD患者成年平均身高较健康同龄人低约0.9 cm。
  • 克罗恩病患者身高降低幅度大于溃疡性结肠炎(-1.3 cm vs -0.6 cm)。
  • 青春期前起病及病程较重者成年身高降低更显著。

核心结论

  • 儿童期起病IBD患者平均成年身高略低于健康同龄人,青春期前起病和病程较重者降低更明显。

研究设计与样本

  • 基于瑞典全国患者登记的人群队列研究,纳入1990-2014年确诊的4201例儿童期起病IBD患者(克罗恩病1640例、溃疡性结肠炎2201例、IBD未分类360例)。

主要发现

  • IBD患者成年身高低于参考个体,校正平均身高差为-0.9 cm(95%CI -1.1至-0.7)。
  • IBD患者成年身高低于健康同胞,校正平均身高差为-0.8 cm(95%CI -1.0至-0.6)。
  • 克罗恩病患者比溃疡性结肠炎患者略矮(-1.3 cm vs -0.6 cm)。
  • 青春期前起病者校正平均身高差为-1.6 cm(95%CI -2.0至-1.2),病程较重者为-1.9 cm(95%CI -2.4至-1.4)。
  • 克罗恩病中5.0%、溃疡性结肠炎中4.3%被归类为生长迟缓,参考个体为2.5%(OR分别为2.42 [95%CI 1.85-3.17]和1.74 [1.36-2.22])。

临床怎么用

  • 对儿童期起病IBD患者应关注青春期前及重症患者的生长监测与身高管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Growth retardation is well described in childhood-onset inflammatory bowel disease (IBD). AIMS: To study if childhood-onset IBD is associated with reduced final adult height. METHODS: We identified 4201 individuals diagnosed with childhood-onset IBD 1990-2014 (Crohn's disease: n = 1640; ulcerative colitis: n = 2201 and IBD-unclassified = 360) in the Swedish National Patient Register. RESULTS: Patients with IBD attained a lower adult height compared to reference individuals (adjusted mean height difference [AMHD] -0.9 cm [95% CI -1.1 to -0.7]) and to their healthy siblings (AMHD -0.8 cm [-1.0 to -0.6]). Patients with Crohn's disease (CD) were slightly shorter than patients with ulcerative colitis (UC; -1.3 cm vs -0.6 cm). Lower adult height was more often seen in patients with pre-pubertal disease onset (AMHD -1.6 cm [-2.0 to -1.2]), and in patients with a more severe disease course (AMHD -1.9 cm, [-2.4 to -1.4]). Some 5.0% of CD and 4.3% of UC patients were classified as growth retarded vs 2.5% of matched reference individuals (OR 2.42 [95% CI 1.85-3.17] and 1.74 [1.36-2.22] respectively). CONCLUSION: Patients with childhood-onset IBD on average attain a slightly lower adult height than their healthy peers. Adult height was more reduced in patients with pre-pubertal onset of disease and in those with a more severe disease course.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Mouratidou N, Malmborg P, Sachs MC, et al. Adult height in patients with childhood-onset inflammatory bowel disease: a nationwide population-based cohort study. Aliment Pharmacol Ther. 2020. PMID: 32133656. doi:10.1111/apt.15667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。